Is DBVT research on Rallies investment advice?

No. Rallies provides research, data, and educational context for DBVT. It does not provide personalized investment advice.

DBVT (DBV Technologies S.A.) Stock Analysis - Financials

DBV Technologies S.A. (DBVT) is a publicly traded Healthcare sector company. As of July 7, 2026, DBVT trades at $15.60 with a market cap of $936.33M and a P/E ratio of -14.83. DBVT moved -1.42% today. Year to date, DBVT is -18.74%; over the trailing twelve months it is +34.57%. Its 52-week range spans $2.20 to $26.19. Analyst consensus is buy with an average price target of $40.97. Rallies surfaces DBVT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are DBVT's key financials?

DBVT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. DBVT recently traded at $15.60. Market cap is $936.33M. P/E ratio is -14.83. Revenue is $5.64M.

DBVT Key Metrics

Key financial metrics for DBVT
Metric	Value
Price	$15.60
Market Cap	$936.33M
P/E Ratio	-14.83
EPS	$-1.05
Dividend Yield	0.00%
52-Week High	$26.19
52-Week Low	$2.20
Volume	154.81K
Avg Volume	0
Revenue (TTM)	$5.64M
Net Income	$-146.95M
Gross Margin	0.00%

DBVT Analyst Consensus

6 analysts cover DBVT: 0 strong buy, 5 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $40.97.

Common questions about DBVT

What are DBVT's key financials?: DBVT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. DBVT recently traded at $15.60. Market cap is $936.33M. P/E ratio is -14.83. Revenue is $5.64M.
Is DBVT research on Rallies investment advice?: No. Rallies provides research, data, and educational context for DBVT. It does not provide personalized investment advice.